PHILIP B DONENBERG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PHILIP B DONENBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PHILIP B DONENBERG. PHILIP B DONENBERG is a SVP and CFO in DEPOMED INC ($DMI) and a CFO, Treasurer and Secretary in ANI PHARMACEUTICALS INC ($ANIP) and a Sr. VP of Finance, CFO & Sec'y in ANI PHARMACEUTICALS INC ($ANIP) and a Chief Financial Officer in AveXis, Inc. ($AVXS) and a Director in AVROBIO, Inc. ($AVRO) and a Director in Taysha Gene Therapies, Inc. ($TSHA).
Address: 111 BARCLAY BLVD SUITE 280 LINCOLNSHIRE 60069 IL
Companies in which PHILIP B DONENBERG is an Insider
ANI PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PHILIP B DONENBERG: Sr. VP of Finance, CFO & Sec'y, CFO, Treasurer and Secretary
Holdings: 42,322 shares
Current Value: $2,630,736
Latest Transaction: Jan 21 2011
$ANIP Market Capitalization: $718.77M
$ANIP Previous Close: $62.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Assertio Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PHILIP B DONENBERG: SVP and CFO
Holdings: 0 shares
Latest Transaction: Jul 16 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AveXis, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PHILIP B DONENBERG: Chief Financial Officer
Holdings: 3,800 shares
Current Value: $224,010
Latest Transaction: May 15 2018
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVROBIO, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PHILIP B DONENBERG: Director
Holdings: 2,000 shares
Latest Transaction: Feb 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Taysha Gene Therapies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PHILIP B DONENBERG: Director
Holdings: 0 shares
Latest Transaction: Sep 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PHILIP B DONENBERG
Sentiment: All, ANIP, DMI, AVXS, AVRO, TSHA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | AVRO | AVROBIO, Inc. | Donenberg Phillip B. | Director | Buy | P | 11.71 | 2,000 | 23,420 | 2,000 | 0 to 2 K |
| Sep 25 2020 | TSHA | Taysha Gene Therap ... | Donenberg Phillip B. | Director | Option Exercise | A | 20.00 | 31,000 | 620,000 | 31,000 | |
| Jun 05 2020 | AVRO | AVROBIO, Inc. | Donenberg Phillip B. | Director | Option Exercise | A | 21.91 | 14,000 | 306,740 | 14,000 | |
| Jun 13 2019 | AVRO | AVROBIO, Inc. | Donenberg Phillip B. | Director | Option Exercise | A | 13.60 | 9,675 | 131,580 | 9,675 | |
| Jul 16 2018 | DMI | DEPOMED INC | Donenberg Phillip B. | SVP and CFO | Option Exercise | A | 0.00 | 87,163 | 0 | 87,163 | |
| Jun 22 2018 | AVRO | AVROBIO, Inc. | Donenberg Phillip B. | Director | Option Exercise | A | 19.00 | 18,743 | 356,117 | 18,743 | |
| Jun 22 2018 | AVRO | AVROBIO, Inc. | Donenberg Phillip B. | Director | Option Exercise | A | 19.00 | 18,743 | 356,117 | 18,743 |